Recruiting
Observational
Longitudinal Investigation of Brain Blood Flow Changes in Neurosurgical Patients
Condition(s) studied
Brain Blood Flow Impairment
Investigational drug(s) / intervention(s)
Advanced imaging investigation
Advanced imaging investigation: MRI imaging
Study summary
Primary study objective:
• Longitudinal observation of brain blood flow changes in neurosurgical patients with or without a neurosurgical intervention as compared to a healthy cohort.
Secondary study objectives:
* Longitudinal observation of hemodynamic patterns versus structural brain tissue changes in neurosurgical patients.
* Changes in blood flow patterns and structural brain tissue after neurosurgical interventions as compared to a healthy cohort.
* Determining hemodynamic imaging patterns that can be tested as novel imaging markers.
Eligibility
Inclusion criteria
Patients:
* Male and Female subjects \>18 years of age
* Written informed consent after participants' information. Foreign speaking patients should be accompanied by a person with sufficient German language proficiency to act as a translator
* Neurosurgical diseases with the potential to alter blood flow to the brain:
* Cerebrovascular disease
* Brain tumors
* Normal Pressure Hydrocephalus
Healthy subjects:
* Male and Female subjects \>18 years of age
* Written Informed Consent by the participant after information about the project. Foreign speaking healthy subjects should be accompanied by a person with sufficient German language proficiency to act as a translator
Exclusion criteria:
Patients:
* Unwilling or unable to co-operate with breathing maneuvers
* Respiratory or cardiac limitations to breathing through a mask
* Medical contra-indications to limited hypercapnia (high CO2 - 50 mmHg) or hypocapnia (low CO2 - 30 mmHg) (i.e., known increased intracerebral pressure, metabolic acidosis or alkalosis)
* Standard contraindications for MRI scanning
* Verbal confirmed pregnancy
* Known multiple intracranial diseases
* Presence of intracranial hemorrhage within the last 3 months
* Symptomatic increased intracranial pressure
Healthy subjects:
* Unwilling or unable to co-operate with breathing maneuvers
* Respiratory or cardiac limitations to breathing through a mask
* Medical contra-indications to limited hypercapnia (high CO2 - 50 mmHg) or hypocapnia (low CO2 - 30 mmHg) (i.e., known increased intracerebral pressure, metabolic acidosis or alkalosis)
* Standard contraindications for MRI scanning
* Verbal confirmed pregnancy
* Anamnesticly a history of neurological disease or current neurological deficits.
Primary outcome measure(s)
- • Longitudinal observation of brain blood flow changes in neurosurgical patients with or without a neurosurgical intervention as compared to a healthy cohort. — 5 years
blood flow changes will be assessed with quantitative blood oxygenation-level dependent cerebrovascular reactivity measurements
Trial sites (1)
| Facility | City | Region | Status |
| University Hospital Zurich |
Zurich |
Switzerland |
Recruiting |
More University of Zurich trials in Switzerland